Log-in / Create Account  
 
DIA 2013 49th Annual Meeting
Click here to go to the previous page
Challenges and Recommendations Related to the Use of ePRO Instruments in Clinical Trials
Track : Track 07: Processes and Technologies for Clinical Research
Program Code: 309
Date: Wednesday, June 26, 2013
Time: 8:00 AM to 9:30 AM  EST
Location: 251
CHAIR :
J. Jason Lundy, PhD (SCHNON), Assistant Director, Patient-Reported Outcome Consortium, Critical Path Institute, United States
SPEAKER (S):
 Elektra Johanna Papadopoulos, DrMed,MPH (SPKAGY), Medical Officer, Office of New Drugs, CDER, FDA, United States
 David S. Reasner, PhD (SPKNON), President and Founder, Albemarle Scientific Consulting LLC, United States
 Keith W. Wenzel, (SPKNON), Senior Director, Global Alliances, Perceptive Informatics, United States
Description
Panelists will discuss the rationale for using electronic data capture and provide methodological recommendations for preparing for the use of ePRO instruments in clinical trials. Challenges to the use of ePRO instruments in clinical trials will be discussed, and recommendations for overcoming these challenges will be provided. Real-world examples of the use of ePRO instruments in clinical trials will be used to illustrate the recommendations.

Session Recording
(Code: 309)
DIA 2013 Attendee:
Attendees Login
  
This session is a part of:
DIA 2013 Live Learning Center
CON4 Comp Access: Wednesday Online Access Package - June 26, 2013
Handout Online
(Code: 309)
DIA 2013 Attendee:
Attendees Login
  
This session is a part of:
DIA 2013 Live Learning Center
CON4 Comp Access: Wednesday Online Access Package - June 26, 2013
Challenges and Recommendations Related to the Use of ePRO Instruments in Clinical Trials